Cargando…

The Contributions of Fiber Atrophy, Fiber Loss, In Situ Specific Force, and Voluntary Activation to Weakness in Sarcopenia

The contributions of fiber atrophy, fiber loss, in situ specific force, and voluntary activation to weakness in sarcopenia remain unclear. To investigate, 40 older (20 women; age 72 ± 4 years) and 31 younger adults (15 women, age 22 ± 3 years) completed measurements. The knee extensor maximal volunt...

Descripción completa

Detalles Bibliográficos
Autores principales: McPhee, Jamie S, Cameron, James, Maden-Wilkinson, Thomas, Piasecki, Mathew, Yap, Moi Hoon, Jones, David A, Degens, Hans
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6132117/
https://www.ncbi.nlm.nih.gov/pubmed/29529132
http://dx.doi.org/10.1093/gerona/gly040
_version_ 1783354260294991872
author McPhee, Jamie S
Cameron, James
Maden-Wilkinson, Thomas
Piasecki, Mathew
Yap, Moi Hoon
Jones, David A
Degens, Hans
author_facet McPhee, Jamie S
Cameron, James
Maden-Wilkinson, Thomas
Piasecki, Mathew
Yap, Moi Hoon
Jones, David A
Degens, Hans
author_sort McPhee, Jamie S
collection PubMed
description The contributions of fiber atrophy, fiber loss, in situ specific force, and voluntary activation to weakness in sarcopenia remain unclear. To investigate, 40 older (20 women; age 72 ± 4 years) and 31 younger adults (15 women, age 22 ± 3 years) completed measurements. The knee extensor maximal voluntary torque (MVC) was measured as well as voluntary activation, patella tendon moment arm length, muscle volume, and fascicle architecture to estimate in situ specific force. Fiber cross-sectional area (FCSA), fiber numbers, and connective tissue contents were also estimated from vastus lateralis biopsies. The MVC, quadriceps volume, and specific force were 39%, 28%, and 17% lower, respectively, in old compared with young, but voluntary activation was not different. The difference in muscle size was due in almost equal proportions to lower type II FCSA and fewer fibers. Five years later (n = 23) the MVC, muscle volume and voluntary activation in old decreased an additional 12%, 6%, and 4%, respectively, but there was no further change in specific force. In situ specific force declines relatively early in older age and reduced voluntary activation occurs later, but the overall weakness in sarcopenia is mainly related to loss of both type I and II fibers and type II fiber atrophy.
format Online
Article
Text
id pubmed-6132117
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-61321172018-09-13 The Contributions of Fiber Atrophy, Fiber Loss, In Situ Specific Force, and Voluntary Activation to Weakness in Sarcopenia McPhee, Jamie S Cameron, James Maden-Wilkinson, Thomas Piasecki, Mathew Yap, Moi Hoon Jones, David A Degens, Hans J Gerontol A Biol Sci Med Sci The Journal of Gerontology: Biological Sciences The contributions of fiber atrophy, fiber loss, in situ specific force, and voluntary activation to weakness in sarcopenia remain unclear. To investigate, 40 older (20 women; age 72 ± 4 years) and 31 younger adults (15 women, age 22 ± 3 years) completed measurements. The knee extensor maximal voluntary torque (MVC) was measured as well as voluntary activation, patella tendon moment arm length, muscle volume, and fascicle architecture to estimate in situ specific force. Fiber cross-sectional area (FCSA), fiber numbers, and connective tissue contents were also estimated from vastus lateralis biopsies. The MVC, quadriceps volume, and specific force were 39%, 28%, and 17% lower, respectively, in old compared with young, but voluntary activation was not different. The difference in muscle size was due in almost equal proportions to lower type II FCSA and fewer fibers. Five years later (n = 23) the MVC, muscle volume and voluntary activation in old decreased an additional 12%, 6%, and 4%, respectively, but there was no further change in specific force. In situ specific force declines relatively early in older age and reduced voluntary activation occurs later, but the overall weakness in sarcopenia is mainly related to loss of both type I and II fibers and type II fiber atrophy. Oxford University Press 2018-09 2018-02-26 /pmc/articles/PMC6132117/ /pubmed/29529132 http://dx.doi.org/10.1093/gerona/gly040 Text en © The Author(s) 2018. Published by Oxford University Press on behalf of The Gerontological Society of America. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle The Journal of Gerontology: Biological Sciences
McPhee, Jamie S
Cameron, James
Maden-Wilkinson, Thomas
Piasecki, Mathew
Yap, Moi Hoon
Jones, David A
Degens, Hans
The Contributions of Fiber Atrophy, Fiber Loss, In Situ Specific Force, and Voluntary Activation to Weakness in Sarcopenia
title The Contributions of Fiber Atrophy, Fiber Loss, In Situ Specific Force, and Voluntary Activation to Weakness in Sarcopenia
title_full The Contributions of Fiber Atrophy, Fiber Loss, In Situ Specific Force, and Voluntary Activation to Weakness in Sarcopenia
title_fullStr The Contributions of Fiber Atrophy, Fiber Loss, In Situ Specific Force, and Voluntary Activation to Weakness in Sarcopenia
title_full_unstemmed The Contributions of Fiber Atrophy, Fiber Loss, In Situ Specific Force, and Voluntary Activation to Weakness in Sarcopenia
title_short The Contributions of Fiber Atrophy, Fiber Loss, In Situ Specific Force, and Voluntary Activation to Weakness in Sarcopenia
title_sort contributions of fiber atrophy, fiber loss, in situ specific force, and voluntary activation to weakness in sarcopenia
topic The Journal of Gerontology: Biological Sciences
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6132117/
https://www.ncbi.nlm.nih.gov/pubmed/29529132
http://dx.doi.org/10.1093/gerona/gly040
work_keys_str_mv AT mcpheejamies thecontributionsoffiberatrophyfiberlossinsituspecificforceandvoluntaryactivationtoweaknessinsarcopenia
AT cameronjames thecontributionsoffiberatrophyfiberlossinsituspecificforceandvoluntaryactivationtoweaknessinsarcopenia
AT madenwilkinsonthomas thecontributionsoffiberatrophyfiberlossinsituspecificforceandvoluntaryactivationtoweaknessinsarcopenia
AT piaseckimathew thecontributionsoffiberatrophyfiberlossinsituspecificforceandvoluntaryactivationtoweaknessinsarcopenia
AT yapmoihoon thecontributionsoffiberatrophyfiberlossinsituspecificforceandvoluntaryactivationtoweaknessinsarcopenia
AT jonesdavida thecontributionsoffiberatrophyfiberlossinsituspecificforceandvoluntaryactivationtoweaknessinsarcopenia
AT degenshans thecontributionsoffiberatrophyfiberlossinsituspecificforceandvoluntaryactivationtoweaknessinsarcopenia
AT mcpheejamies contributionsoffiberatrophyfiberlossinsituspecificforceandvoluntaryactivationtoweaknessinsarcopenia
AT cameronjames contributionsoffiberatrophyfiberlossinsituspecificforceandvoluntaryactivationtoweaknessinsarcopenia
AT madenwilkinsonthomas contributionsoffiberatrophyfiberlossinsituspecificforceandvoluntaryactivationtoweaknessinsarcopenia
AT piaseckimathew contributionsoffiberatrophyfiberlossinsituspecificforceandvoluntaryactivationtoweaknessinsarcopenia
AT yapmoihoon contributionsoffiberatrophyfiberlossinsituspecificforceandvoluntaryactivationtoweaknessinsarcopenia
AT jonesdavida contributionsoffiberatrophyfiberlossinsituspecificforceandvoluntaryactivationtoweaknessinsarcopenia
AT degenshans contributionsoffiberatrophyfiberlossinsituspecificforceandvoluntaryactivationtoweaknessinsarcopenia